HIGHLIGHTS
- who: Ismail Celil Haskologlu and colleagues from the (UNIVERSITY) have published the research: The Concomitant Use of Melatonin and Molnupiravir in the Treatment of COVID-19: Mini Review, in the Journal: (JOURNAL)
- what: This study was conducted in unvaccinated adults who were at risk forprogression to severe disease and resultsof the study showed that molnupiravir was effective agent with no safety concerns. This study shows that molnupiravirremains an effective and preferred antiviral agent for SARSCoV-2 Omicron variant infection.
SUMMARY
The World Health Organization (WHO) declaredcoronavirus disease (COVID-19) a pandemic . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.